Skip to main content
OpenTrials
Completed

NCT Number: NCT03657875

Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)

This is a cross-sectional retrospective study of laboratory records of patients who take electrolytes blood tests containing the data of the serum potassium level. This study is an observational one, and there is no intervention into routine clinical practice either in terms of therapy, or special examinations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperkalemia Elevated Plasma K+ Cardiovascular Disease (CVD)

Sex eligibility

All sexes

Study type

Observational

Primary location

Invitro

Moscow, Russia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females tested in the Russian centres of INVITRO laboratory from 01.01.2015 till 31.12.2016;
  • 18 years and older;
  • Available electrolytes blood test containing of the serum potassium level of the unique patient fits for interpretation.

Exclusion criteria

  • Blood test cannot be interpreted due to various reasons.
  • Blood samples with sing of hemolysis

Treatment and study plan

Primary outcomes

  1. the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L

    Time frame: One day

    To determine the proportion of the individuals with the serum potassium level higher than 5.0, 5.5, and 6.0 mmol/L based on INVITRO laboratory database during 2015-2016 years.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Sep 5, 2018
Registry last updated
Sep 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.